Serial Number
86501039
Owner
Consortium de recherche en oncologie cli nique du QuébecAttorney
Michelle P. CiotolaFiling Date
Jan 12, 2015
Q-CROC Trademark
Serial Number: 86501039 • Registration: 5163786
Trademark Classes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Laurier
Québec (Québec) G1V0B9 , CA
Entity Type: 99
Legal Representation
Trademark Details
Filing Date
January 12, 2015
Registration Date
March 21, 2017
Published for Opposition
January 3, 2017
Cancellation Date
October 6, 2023
Goods & Services
Conducting seminars in the field of oncology; Conducting workshops and seminars in the field of clinical trials and research; Educational services, namely, providing classes, seminars and workshops in the fields of oncology and clinical trials and research; educational services, namely, organizing seminars, panel discussions for working and research groups, and conferences, in the field of human cancer; organization of educational forums for cancer research
Clinical trial management services, namely, providing clinical administrative and office support services for organizations and researchers in the field of oncology research in the nature of clearing house for information about clinical trials between industry and clinical community, promoting awareness of clinical trials and necessity of funding for such trials, creating a commercial directory of available resources for healthcare organization, compilation and management of clinical trial updates, providing advisory services and preparation of budgets, development and collection of data and performance metrics for business purposes
Medical and scientific research in the field of oncology; Medical research services in the field of human cancer; Medical and scientific research, namely, consulting on clinical trials; Providing medical and scientific research information in the area of human cancer; medical and scientific research in the field of therapeutic resistance to cancer, namely, conceiving, developing and managing biopsy-driven studies with biomarker discovery/validation, creating unique banks of biospecimens with platforms, identifying biomarkers of therapeutic resistance, providing expertise on translational projects, facilitating collaborations between basic scientists, clinical teams and the industry professionals
